This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Vitamin C plaintiffs ask for contempt finding, saying Chinese pharma company refuses to pay up

( March 20, 2015, 23:31 GMT | Official Statement) -- MLex Summary: Hebei Welcome Pharmaceutical should be held in contempt and its assets placed into a receivership for failing to honor a judgment after a trial court found that it fixed prices on vitamin C, plaintiffs said in a motion. The company has defied a court order requiring it to turn over records on its assets, effectively stopping plaintiffs from collecting money owed in connection with a $148 million judgment, they said. Hebei has argued that turning over the records violates US law and asked collection to be put on hold pending the outcome of its appeal in the case.See document below....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections